Medical Nutrition Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type (Proteins, Carbohydrates, Multivitamins, Antioxidants, Fibers, Trace elements, Supplements, and Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, Obesity, Malnutrition, and Pulmonary disease), By End User (Pediatric Nutrition, Geriatric Nutrition, Sports Nutrition, and Adult Nutrition), By Route of Administration (Oral, Parenteral, and Enteral), and Region

Medical Nutrition Market size was valued at USD 48.9 billion in 2023 and is poised to grow at a CAGR of 3.7% from 2024 to 2030. Medical nutrition is an evidence-based, individualised nutrition process to help treat certain medical conditions. It is a relationship between diet, nutrition, and health outcomes. It includes giving the right foods or nutrients to treat conditions such as those caused by diabetes, heart disease, and cancer. The increasing prevalence of metabolic disorders, high spending on healthcare, and increasing disposable income of the public are expected to drive the growth of the

global medical nutrition market over the forecast period. Besides this, various government initiatives like celebration of National Nutrition Month, the UN Decade of Action on Nutrition and others are booming the major influencers of global medical nutrition market growth. Furthermore, collaborations, partnerships, mergers, and acquisitions are stipulating the growth of the market. For instance, In September 2023, RxFood Corporation, a company specializing in AI-driven personalized nutrition assessments, and Dexcom, Inc., a global leader in real-time continuous glucose monitoring (rtCGM) for individuals with diabetes, announced a unique partnership in Canada. However, side effects and complications of nutritional products, product recalls, and stringent regulations pose a threat to manufacturers.

Medical Nutrition Market Key Developments:

• In September 2020, Baxter announced that Clinimax and Clinimax E have been approved by the U.S. FDA (Food and Drug Administration). These contain more proteins (amino acids), carbohydrates, lipids (fats), electrolytes, vitamins, and other trace components and are intended for patients who need parenteral nourishment to assist prevent malnutrition. 
• In November 2023, Danone S.A., a global nutrition company, announced that it had launched Fortimel medical nutrition products in the adult foods for special medical purposes category in China. Fortimel is designed to meet the nutritional needs of patients recovering after surgery or non-communicable diseases like cancer & stroke and complements Danone’s existing offering of adult medical nutrition for tube feeding.